BioNTech, the German firm behind the first licensed coronavirus jab, reveals its attempts to stuff its technology into shipping containers—to be used where they are most needed. In the second instalment of our French-election series, we ask what is left of the country’s left. And, as the Olympics wrap up, putting numbers to judges' biases that favour their compatriots. For full access to print, digital and audio editions of The Economist, subscribe here www.economist.com/intelligenceoffer
 See acast.com/privacy for privacy and opt-out information.